A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
5-Hydroxyindoleacetic Acid (5-HIAA), 24-Hour Urine without Creatinine
Test CodeAlias/See Also
LAB2910
CPT Codes
<p>83497</p>
Includes
Preferred Specimen
Patient Preparation: Patient should avoid food high in indoles: avocado, banana, tomato, plum, walnut, pineapple, and eggplant.
Specimen Type: Urine
Collection Container/Type
Preferred: 24-hour urine (preserved: 25 mL 6N HCl)
Acceptable: 24-hour urine (unpreserved with a pH ≤6)
Submission Container/Tube: Sterile container
Specimen Volume: 10 mL
Collection Instructions:
- Collect 24-hour urine with 25 mL 6N HCl to maintain a pH ≤3.
- If no preservative is used, specimen must be stored refrigerated during collection but shipped frozen and pH must be ≤6.
- Record 24-hour urine volume and patients age on test request form and urine container.
Patient Preparation
Patient should avoid food high in indoles: avocado, banana, tomato, plum, walnut, pineapple, and eggplant
Minimum Volume
5 mL
Other Acceptable Specimens
Instructions
Collect 24-hour urine with 25 mL 6N HCl to maintain a pH ≤3. If no preservative is used, specimen must be stored refrigerated during collection but shipped frozen and pH must be ≤6.
Record 24-hour urine volume and patient's age on test request form and urine container.
Transport Temperature
Unpreserved urine: Frozen
Specimen Stability
Preserved urine
Room temperature: 7 days
Refrigerated: 30 days
Frozen: 30 days
Unpreserved urine
Room temperature: Unacceptable
Refrigerated: Unacceptable
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved urine received refrigerated with a pH >3 • Unpreserved urine received frozen with pH >6
Methodology
High Performance Liquid Chromatography (HPLC)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Report Available
1-3 days
Limitations
Patients with renal disease may display falsely decreased results. Urinary 5-HIAA is increased in patients with malabsorption disorders who also display a larger concentration of urinary tryptophan metabolites. Urinary 5-HIAA is increased in patients with intestinal obstruction and with some noncarcinoid islet cell tumors. Carcinoid syndrome may not cause elevated results, especially if the patient does not have diarrhea.
Reference Range
<2 Years | Not established |
2-10 Years | ≤8.0 mg/24 h |
>10 Years | ≤6.0 mg/24 h |
Clinical Significance
Performing Laboratory
Quest Diagnostics Nichols Inst San Juan Capistrano
33608 Ortega Highway
San Juan Capistrano, CA 92690-6130
Last Updated: February 17, 2023